Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism

NCT: NCT05555940 · COMPLETED

NCT IDNCT05555940
StatusCOMPLETED
Start Date2022-10-01
Completion2024-11-30

Brief Summary

This study aims to explore and investigate the therapeutic effect and mechanism of individualized localization of transcranial magnetic stimulation on emotional blunting of depression, improve the understanding of the mechanism of emotional blunting of depression, order to provide new treatment methods and better curative effects for this disease.

Frequently Asked Questions

What is Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism?

Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism is a clinical trial registered under NCT05555940. Current status: COMPLETED.

What is the status of NCT05555940?

The current status of NCT05555940 (Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism) is: COMPLETED.

When did Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism start?

Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism started on 2022-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑